Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation
Keywords: RIF; repeated embryo implantation failure; uNKcells; uterine natural killer cells; Intralipid®; IVF/ICSI; Uterine receptivity; Implantation failures; Pregnancy;